Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 696-042-8 | (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3- yl)piperazin-1-yl]methyl}-cyclohexyl]methyl}-4- azatricyclo[5.2.1.0^{2,6}]decane-3,5-dione | 367514-87-2 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| STOT SE 3 | H336 (central nervous...) | H336 |
GHS07 GHS08 Wng |
State/Form
|
1 |  |
View details | ||||
| Carc. 2 | H351 | H351 | |||||||||
| Acute Tox. 4 | H302 |
GHS07 GHS08 Wng |
State/Form
|
1 | View details | ||||||
| H302+H332 | |||||||||||
| Skin Sens. 1 | H317 | H317 | |||||||||
| Acute Tox. 4 | H332 | ||||||||||
| Repr. 2 | H361 (fd) | H361 (fd) | |||||||||
| Skin Sens. 1 | H317 | H317 |
GHS08 GHS07 Wng |
State/Form
|
1 | View details | |||||
| Carc. 2 | H351 | H351 | |||||||||
| Aquatic Chronic 4 | H413 | H413 | |||||||||
Number of Aggregated Notifications: 3